Skip to content
homeHOME About Yuhan CEO’s Greeting

CEO’s Greeting

Today, Yuhan continues to grow as a global company, with the wellness of people as our first priority.

Yuhan Corporation’s story began with Dr. Ilhan New’s commitment to his country: to provide his fellow Koreans with the best medications and treatments available. Now, over 80 years later, the spirit of our founder continues to drive Yuhan forward as we reach out to the world, to improve the health and well-being of people everywhere. Yuhan’s willow tree, the literal translation of Dr. New’s surname, has become our symbol of integrity. It represents not only the quality of our products, but the ethics, transparency and social responsibility of our management philosophy as well.

Today, Yuhan continues to grow as a global company, with the wellness of people as our first priority.
Yuhan’s state-of-the-art research and development facilities are where it all begins. Our focused R&D efforts have yielded Revanex, a new acid-pump antagonist designed to treat gastric ulcers, as well as a number of new drug entities for antibiotics, cancer, hepatitis C, arthritis, osteoporosis, and other conditions.
Completed in 2006, our Ochang General Formulations Plant is highly automated and in full compliance with current Good Manufacturing Practices (cGMP). It features scalable, flexible production lines and advanced logistics systems, giving Yuhan the capability to bring high-quality medicines to market and to patients quickly and efficiently.

Our large-scale Shi Hwa Synthetic Plant, opened in 1998, remains at the leading edge of pharmaceutical technology. Both Ochang and Shi Hwa are approved by the United States Food and Drug Administration (FDA), the European Medicines Agency and the European.
Directorate for the Quality of Medicines (EMEA/EDQM), Australia’s Therapeutic Goods Administration (TGA), Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), and other regulatory organizations. Together, these plants allow us deliver active pharmaceutical ingredients (APIs), manufactured to the highest standards, to our partners around the globe.

Yuhan is prepared, with new ideas and methods, to take the lead toward a future filled with new pharmaceutical discoveries and continuing growth. As we endeavor to earn the trust of our customers and uphold our social responsibilities, Yuhan will create greater value for our stakeholders through ongoing innovation and international expansion.
Yuhan will always be with you, our customers and
partners, to create a healthier and more prosperous society.